ABSTRACT -Background -Variceal bleeding has a high mortality among cirrhotics, and screening with endoscopy is indicated at the diagnosis of cirrhosis.
INTRODUCTION
Cirrhotic patients have esophageal varices (EV) in up to 60% of cases, and variceal bleeding is associated to a mortality rate of 15%-20% (2) . This is why the American Association for the Study of Liver Disease (7) and the Baveno Consensus (5) advise the screening of EV in cirrhotics. Actually, according to the Baveno Consensus (5) the only patients who might safely avoid a screening endoscopy would be those with compensated advanced chronic liver disease and both a liver stiffness measurement under 20 kPa and a platelet count over 150,000/mm 3 , which was validated in a recent study (1) . Nevertheless, important societies do not support using any noninvasive test instead of endoscopy for variceal screening (6) . Screening with endoscopy implies discomfort, risks and considerable costs, which is even more important when one considers public health systems. In an attempt to reduce distress for patients and costs, many non-invasive methods to screen for EV are being studied. When we evaluated two of these methods, namely, platelet count/spleen diameter ratio (PC/SD) (8) and aspartate aminotransferase-to-platelet ratio index (APRI) (13) , despite being associated to the presence of EV in the univariate analysis, none of them was independently related to it. Actually, the variable associated to EV in the multivariate analysis of both studies was platelet count (8, 13) . Therefore, considering the importance of platelet count in pre-dicting EV, we have tried to develop a model which would increase the value attributed to platelet count in predicting EV, as well as control it by a portal hypertension parameter, spleen diameter (2) , and by a fibrosis parameter, APRI (10) . This study analyzes the ability of platelet count squared/spleen diameter-aspartate aminotransferase ratio (PS/SA) in predicting the existence of EV in a population of cirrhotic patients.
METHODS
Records of patients from the outpatient clinic of cirrhosis of a general hospital in Southern Brazil were reviewed for this crosssectional study. Records should inform platelet count, spleen diameter, aspartate aminotransferase (AST) and endoscopy 6 months apart from each other at most. Endoscopists were not aware of PS/SA results. EV were not classified in size for the purpose of this study because even small varices are likely to bleed if presenting with red marks or in Child-Pugh class C patients, situations in which prophylaxis is already indicated (5, 7) . Spleen diameter was determined by ultrasonography, which was performed in all patients by the same group of radiologists.
PS It was calculated that at least 139 patients were needed to produce results with a 95% level of confidence and a 10% length for the confidence intervals. This study was approved by the institutional Ethics Committee (reference number 1624.07), according to the Declaration of Helsinki of 1975. The institutional Ethics Committee considered that informed consent was not necessary for the present study.
RESULTS
One hundred and sixty four patients were consecutively included in the study, from which 98 were men (59.76%). The mean age of the patients was 56.7 years. Hepatitis C was present in 90 patients, and alcohol abuse, in 63 (some of the patients had both risk factors for liver disease). Patients were classified as Child-Pugh A in 86 cases (52.44%) and as Child-Pugh B or C in 78 cases (47.56%). EV were diagnosed by endoscopy in 119 patients (72.56%). Other baseline characteristics of patients are shown in Table 1 8 . In the univariate analysis, PS/SA (P<0.001), APRI (P<0.001), platelet count (P=0.001), spleen diameter (P=0.015), PC/SD (P<0.001), MELD score (P=0.017) and Child-Pugh classification (P=0.015) were associated to the presence of EV. The only studied variable not associated to EV was the AST/ALT ratio (P=0.512). When the logistic regression was performed, though, only platelet count and Child-Pugh classification were independently associated to the presence of EV (P<0.050).
DISCUSSION
Defining cirrhotics at a greater risk for EV in a non-invasive manner is essential in order to reduce costs, discomfort and risks related to endoscopy. Endoscopy is an invasive and expensive procedure, which could be unnecessary in part of the patients diagnosed with cirrhosis. For a non-invasive test to be considered useful in the studied context, it should have a great sensitivity, since misdiagnosing cirrhotic patients as not having EV is a major risk, and it should be of low cost.
PC/SD, for instance, is a very low cost alternative, because it uses parameters which are part of every cirrhotic workup. Nevertheless, the systematic reviews published on this subject reached contradictory conclusions (3, 12) . More recently, elastography (4, 11) has been studied for the prediction of EV. Results, though not ideal, could be considered acceptable, but the high costs associated to elastography and its low availability do not allow it to be a good substitute for endoscopy at the moment (9) . The same could be said about the prediction of varices needing prophylaxis by a liver stiffness measurement under 20 kPa and a platelet count over 150,000/mm 3 , which was suggested by the Baveno Consensus (5) and recently validated (1) . PS/SA uses three easily obtained parameters, which are part of the routine workup of cirrhotics and, thus, would not increase costs. Besides, the index presented a very good sensitivity, especially at the cutoff of 3x10 8 , which would allow almost 25% of patients without EV to avoid endoscopy.
Sensitivity is the most important characteristic of a screening test. Comparing the sensitivity of PS/SA to that of other promising non-invasive methods for prediction of EV, namely PC/SD and transient elastography, the index that we are now presenting performs well. Considering the results of 2 meta-analyses on PC/ SD, the sensitivity of the method varies between 89% and 92% (3, 12) , while we have shown sensitivities as high as 95.80% for PS/SA. Regarding elastography, different articles described a wide range of sensitivity values, varying from 67.00% (11) to 96.20% (4) . Compared to the sensitivity of elastography, the sensitivity of PS/SA is better or, at least, similar. Again, one must take into consideration that elastography implies high costs, especially in developing countries, while PS/SA does not. Nevertheless, despite the good sensitivity of the method, PS/SA was not independently associated to EV in the multivariate analysis, which might be explained by the presence of confounding factors. One hundred and fifty three patients had complete data in order for the calculation of PS/SA. Among these patients, 114 had EV (74.51%). The mean value of the index for patients without EV was 256,621,745.22 (standard deviation-SD=353,210,019.27), while, for patients with EV, it was 77,743,669.49 (SD=189,389,006.13). When the index, at a cutoff of 2x10 7 , was used in order to predict the existence of EV (i.e. patients with an index greater than 2x107 were predicted not to have EV, while patients with an index equal or inferior to 2x107 were predicted to have EV), it had a sensitivity of 50.80% (95%CI=0.42-0.60), a specificity of 65.90% (95%CI=0.52-0.80), a positive predictive value of 80.30% (95%CI=0.71-0.89) and a negative predictive value of 33.00% (95%CI=0.23-0.43). For a cutoff of 2x10 8 , the index had a sensitivity of 90.80%
CONCLUSION
In conclusion, though PS/SA is not independently associated to EV, it has an excellent sensitivity, better than most of other noninvasive methods for the prediction of EV. Since its use could allow almost one fourth of patients without EV to spare endoscopy, therefore saving costs, we believe this index should be further evaluated.
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